Ref EJVES MAY 2016
The answer is yes, if we look at this case control study. Identifying 6 afferent vessels, or the presence of AAA thrombus volume ratio (VR%) <40% have been shown clearly and significantly to be asociatied with increas type II risk rate, and that emboli station of which has reduced significantly the type II endoleak when compared to a arching group 30% vs 75% at 6 months and similar at 12 months.
So it is so correct to presume this is a first step towards reducing the annoying type II endoleak risk.